Sridhar Narayan, Ph.D, EMBA candidate
Sridhar Narayan is a scientist and entrepreneur who brings extensive experience from the life sciences industry. He’s currently the Head of Drug Discovery and Development at Satellos Bioscience, which he helped launch in 2018. In 2015, he was involved in starting Appili Therapeutics where he serves as Project Director and Member of the Scientific Advisory Board. Sridhar also consults with biotech and VC firms on new ventures, drug discovery & development, strategy, and business development. Previously, Sridhar held scientific leadership positions at Navitor Pharmaceuticals, AstraZeneca and Eisai, where he led projects from early discovery through IND and FIH studies. He has a track record of moving several compounds into clinical development and his expertise spans oncology, immunology/ inflammation, metabolic disorders, CNS and infectious diseases. Sridhar received his PhD from the University of Michigan and carried out postdoctoral research at the Scripps Research Institute. He’s in the Executive MBA program at the Yale School of Management.